NO985214L - Inhibitorer for produksjon av s-CD23 og sekresjon av TNF - Google Patents

Inhibitorer for produksjon av s-CD23 og sekresjon av TNF

Info

Publication number
NO985214L
NO985214L NO985214A NO985214A NO985214L NO 985214 L NO985214 L NO 985214L NO 985214 A NO985214 A NO 985214A NO 985214 A NO985214 A NO 985214A NO 985214 L NO985214 L NO 985214L
Authority
NO
Norway
Prior art keywords
alkyl
aryl
alkenyl
hydroxy
carboxy
Prior art date
Application number
NO985214A
Other languages
English (en)
Other versions
NO985214D0 (no
Inventor
Stuart Bailey
Derek Richard Buckle
Andrew Faller
David Glynn Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO985214D0 publication Critical patent/NO985214D0/no
Publication of NO985214L publication Critical patent/NO985214L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Forbindelser med formel (I): HON NHR3 ROR' (I) hvor: R er hydroksy, hydrogen, alkyl, alkenyl, alkynyl eller aryl; R"1 er arylmetyl eller heterocyklylmetyl; R2 er alkyl, alkenyl, aryl, cykloalkyl eller cykloalkenyl; og R3 er hydrogen, alkyl, alkenyl, alkynyl eller aryl; med det forbehold at; hvis R1 er fenylmetyl eller naftylmetyl, hvor fenyl- eller naftylgruppen er usubstituert eller substituert med opptil fem substituenter valgt fra gruppen bestående av halogen, (Ci_6)alkyl, aryl(Ci_6)alkyl, (Ci_6)alkoksy, (C-).6)alkoksy(c1-6)alky1- halogen(Ci_6)alkyl, hydroksy, nitro, amino, mono- og di-A/-(C<|-6)alkylamino, acylamino, acyloksy, karboksy, karboksy salter, karboksyestere, karbamoyl, mono- og di-A/-(Ci_6)alkylkarbamoyl, (Ci-6)alkoksykarbonyl, aryloksykarbonyl, ureido, guanidino, sulfonylamino, aminosulfonyl, (Ci_6)alkyltio, (Ci_6)alkylsulfinyl (C-j-6)alkylsulfonyl, heterocyklyl, heterocyklyl(Ci_6)alkyl og en (Cs-5)alkylenkjede som binder sammen to ringkarbonatomer i nabostilling under dannelse av en karbocyklisk ring; da R er hydroksy; er nyttige ved behandling av lidelser betinget av s-CD23.
NO985214A 1996-05-10 1998-11-09 Inhibitorer for produksjon av s-CD23 og sekresjon av TNF NO985214L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9609794.4A GB9609794D0 (en) 1996-05-10 1996-05-10 Novel compounds
PCT/EP1997/002433 WO1997043249A1 (en) 1996-05-10 1997-05-06 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF

Publications (2)

Publication Number Publication Date
NO985214D0 NO985214D0 (no) 1998-11-09
NO985214L true NO985214L (no) 1998-12-01

Family

ID=10793494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985214A NO985214L (no) 1996-05-10 1998-11-09 Inhibitorer for produksjon av s-CD23 og sekresjon av TNF

Country Status (21)

Country Link
US (1) US6235753B1 (no)
EP (1) EP0918747B1 (no)
JP (1) JP2000510473A (no)
KR (1) KR20000010892A (no)
AR (1) AR007060A1 (no)
AT (1) ATE246673T1 (no)
AU (1) AU2897397A (no)
BR (1) BR9709450A (no)
CA (1) CA2253590A1 (no)
CO (1) CO4990945A1 (no)
CZ (1) CZ363198A3 (no)
DE (1) DE69723984T2 (no)
ES (1) ES2205218T3 (no)
GB (1) GB9609794D0 (no)
IL (1) IL126860A0 (no)
NO (1) NO985214L (no)
NZ (1) NZ332628A (no)
PL (1) PL329855A1 (no)
TR (1) TR199802271T2 (no)
WO (1) WO1997043249A1 (no)
ZA (1) ZA973964B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082200A1 (en) * 1994-07-13 2002-06-27 Smithkline Beecham P.1.C. Use of inhibitors of human S-CD23
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
CA2308361A1 (en) 1997-11-12 1999-05-20 Andrew Douglas Baxter Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
GB9813451D0 (en) * 1998-06-22 1998-08-19 Smithkline Beecham Plc Novel compounds
GB9922825D0 (en) * 1999-09-25 1999-11-24 Smithkline Beecham Biolog Medical use
WO2001038322A1 (en) 1999-11-23 2001-05-31 Methylgene, Inc. Inhibitors of histone deacetylase
GB9930754D0 (en) * 1999-12-29 2000-02-16 Smithkline Beecham Plc Novel compounds
JP4790594B2 (ja) * 2003-02-25 2011-10-12 トポターゲット ユーケー リミテッド Ｈｄａｃインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物
GB0818907D0 (en) * 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
MX2011012627A (es) 2009-05-28 2011-12-14 Novartis Ag Derivados aminobutiricos sustituidos como inhibidores de nepralisina.
EP2594557B1 (en) * 2009-05-28 2016-08-10 Novartis AG Substituted aminopropionic derivatives as neprilysin inhibitors
EP2860195A1 (en) 2009-12-01 2015-04-15 Boston Medical Center Corporation Treatment of IgE-mediated disease
EA026989B1 (ru) 2013-02-14 2017-06-30 Новартис Аг Производные замещенной бисфенилбутановой кислоты в качестве ингибиторов nep с улучшенной in vivo эффективностью
CN105073762B (zh) 2013-02-14 2017-03-08 诺华股份有限公司 作为nep(中性内肽酶)抑制剂的取代的联苯丁酰膦酸衍生物
TW201625569A (zh) * 2014-11-19 2016-07-16 艾克泰聯製藥有限公司 抗菌性苯并噻唑衍生物
AU2019352741A1 (en) 2018-10-04 2021-05-06 Assistance Publique-Hôpitaux De Paris (Aphp) EGFR inhibitors for treating keratodermas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215665D0 (en) 1992-07-23 1992-09-09 British Bio Technology Compounds
DK0822186T3 (da) * 1994-01-20 2000-06-26 British Biotech Pharm L-tert-leucin-2-pyridylamid
GB9414157D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Medical use
US5562917A (en) 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
DE19506492C2 (de) 1995-02-24 2003-05-08 Focke & Co Einrichtung zum Speichern von Zigaretten oder dergleichen
US5570079A (en) 1995-04-24 1996-10-29 Dockery; Devan Home security system for detecting an intrusion into a monitored area by an infrared detector

Also Published As

Publication number Publication date
ZA973964B (en) 1998-11-09
CO4990945A1 (es) 2000-12-26
TR199802271T2 (xx) 2000-08-21
US6235753B1 (en) 2001-05-22
IL126860A0 (en) 1999-09-22
ES2205218T3 (es) 2004-05-01
CA2253590A1 (en) 1997-11-20
JP2000510473A (ja) 2000-08-15
WO1997043249A1 (en) 1997-11-20
GB9609794D0 (en) 1996-07-17
NZ332628A (en) 2000-06-23
AR007060A1 (es) 1999-10-13
DE69723984D1 (de) 2003-09-11
BR9709450A (pt) 1999-08-10
ATE246673T1 (de) 2003-08-15
DE69723984T2 (de) 2004-06-09
PL329855A1 (en) 1999-04-12
KR20000010892A (ko) 2000-02-25
CZ363198A3 (cs) 1999-06-16
AU2897397A (en) 1997-12-05
EP0918747B1 (en) 2003-08-06
NO985214D0 (no) 1998-11-09
EP0918747A1 (en) 1999-06-02

Similar Documents

Publication Publication Date Title
NO985214L (no) Inhibitorer for produksjon av s-CD23 og sekresjon av TNF
PT729455E (pt) Arilpiperazinas derivadas de indol como ligados para os receptores 5ht1-like, 5ht1b e 5ht1d
MX9203249A (es) Derivados del acido bencimidazolin-2-oxo-1-carboxilico y composiciones farmaceuticas que los contienen.
NZ511394A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
CA2229000A1 (en) 1-biphenylimidazole derivatives, their preparation and their therapeutic use
FI932229A (fi) Azabicykliska bryggderivat
ATE298316T1 (de) Wässrige dispersionen, aufgebaut aus polycarbodiimiden
SE8002904L (sv) Forfarande for framstellning av derivat av omettad 7-acylamido-3-cefem-4-karboxylsyra
DK0711291T3 (da) N-(Piperidinyl-1-alkyl)-substituerede cyclohexancarboxylsyreamider som 5-HT1A-receptorantagonister
HUP0203787A2 (hu) Hidroxi-acetil-piperazinnal szubsztituált oxazolidinon-benzoesav-észterek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AU5247993A (en) Antiretroviral hydrazine derivatives
KR850002463A (ko) N-(티오)카바모일아릴(티오)카복스이미드산 에스테르의 제조방법
AU8445591A (en) N-(mercaptoalkyl)ureas and carbamates
ES8301237A1 (es) Un procedimiento para la preparacion de un derivado 2-tiope-nem
ATE113588T1 (de) Heterocyclisch substituierte alkyl- und alkenylsulfonylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als herbizide oder pflanzenwachstumsregulatoren.
ES2114676T3 (es) Derivados substituidos del acido orto-etenilfenilacetico.
MY110826A (en) Cyanoguanidines as k-channel blockers
AU5674894A (en) Azanoradamantanes
EP0116432A3 (en) Improvements in or relating to n-(substituted-methyl)-azetidin-2-ones
DE69416311T2 (de) Verwendung von cephem-derivaten als antimetastatische mittel
HK1000551A1 (en) Ocular tension depressant
SE436870B (sv) Sett att framstella nya n-substituerade kanelsyraamider
GB1151450A (en) Arylsulphonylureas and -Thioureas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application